ISTRADEFYLLINE

ISTRADEFYLLINE was reported 5984 times

ISTRADEFYLLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOLLICULITIS BARBAE 1 0.2500
1 DEVICE PRIMING 1 0.0435
2 DOPAMINE AGONIST WITHDRAWAL SYNDROME 2 0.0370
3 STOMA SITE CELLULITIS 2 0.0351
4 DEEP BRAIN STIMULATION 17 0.0281
5 DEVICE EFFECT DECREASED 1 0.0256
6 FREEZING PHENOMENON 92 0.0248
7 EMERGENCY CARE 72 0.0237
8 PARKINSONISM HYPERPYREXIA SYNDROME 4 0.0223
9 SOMATIC HALLUCINATION 2 0.0222
10 CATHETER SITE PAPULE 1 0.0185
11 FLUID INTAKE RESTRICTION 2 0.0182
12 TOE WALKING 2 0.0171
13 IMPULSE-CONTROL DISORDER 35 0.0170
14 CENTRAL AUDITORY PROCESSING DISORDER 1 0.0167
15 ON AND OFF PHENOMENON 90 0.0162
16 HOME CARE 1 0.0156
17 SPINAL SUBDURAL HAEMATOMA 2 0.0154
18 CARDIAC DEVICE IMPLANTATION 1 0.0137
19 DELUSION OF PARASITOSIS 2 0.0127
20 PRODUCT DISPENSING ISSUE 54 0.0126
21 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 5 0.0124
22 NASAL MUCOSAL DISCOLOURATION 2 0.0124
23 DYSKINESIA 484 0.0119
24 DEPENDENT PERSONALITY DISORDER 2 0.0110
25 PATIENT ELOPEMENT 4 0.0109
26 DEFICIENCY ANAEMIA 1 0.0105
27 INFUSION SITE PAPULE 1 0.0105
28 DELUSION OF REPLACEMENT 1 0.0100
29 STOMA SITE HYPERGRANULATION 6 0.0095
30 CAROTID ARTERY STENT INSERTION 1 0.0093
31 GASTROENTEROSTOMY 1 0.0092
32 COMPULSIONS 6 0.0090
33 CAMPTOCORMIA 2 0.0083
34 STOMA SITE ABSCESS 2 0.0082
35 HALLUCINATION 617 0.0082
36 PATIENT DISSATISFACTION WITH DEVICE 2 0.0079
37 STOMA SITE EXTRAVASATION 3 0.0078
38 INFUSION SITE CELLULITIS 4 0.0076
39 FEAR OF FALLING 6 0.0074
40 STOMA SITE PAIN 10 0.0068
41 SLEEP TALKING 11 0.0065
42 ATTENTION-SEEKING BEHAVIOUR 1 0.0064
43 PNEUMOCEPHALUS 2 0.0060
44 SALIVA DISCOLOURATION 2 0.0060
45 APPLICATION SITE INDURATION 1 0.0059
46 CARDIOACTIVE DRUG LEVEL DECREASED 1 0.0058
47 STOMA SITE REACTION 4 0.0058
48 MULTIPLE SYSTEM ATROPHY 2 0.0057
49 MEDICAL DEVICE CHANGE 3 0.0056
50 THERAPY NON-RESPONDER 252 0.0056
51 FEEDING TUBE USER 2 0.0055
52 APPLICATION SITE INJURY 1 0.0053
53 CATHETER SITE NODULE 1 0.0052
54 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
55 DEVICE COLOUR ISSUE 2 0.0050
56 LIBIDO INCREASED 10 0.0049
57 THERAPEUTIC PRODUCT EFFECT VARIABLE 19 0.0049
58 INFUSION SITE INDURATION 7 0.0047
59 IMMOBILISATION SYNDROME 1 0.0047
60 GASTROINTESTINAL HYPERMOTILITY 2 0.0047
61 STOMA SITE INFECTION 6 0.0046
62 HALLUCINATION, OLFACTORY 2 0.0046
63 DOPAMINE DYSREGULATION SYNDROME 2 0.0045
64 STOMA SITE ERYTHEMA 8 0.0043
65 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
66 INTUSSUSCEPTION 4 0.0042
67 INFUSION SITE NODULE 4 0.0042
68 DYSLALIA 3 0.0041
69 REHABILITATION THERAPY 16 0.0041
70 HELMINTHIC INFECTION 1 0.0041
71 ILLNESS ANXIETY DISORDER 1 0.0041
72 STOMA SITE INFLAMMATION 3 0.0040
73 CATHETER SITE RELATED REACTION 3 0.0040
74 DEVICE CONNECTION ISSUE 8 0.0038
75 BRADYKINESIA 22 0.0037
76 BINGE EATING 4 0.0037
77 COMPULSIVE SEXUAL BEHAVIOUR 3 0.0037
78 HALLUCINATION, VISUAL 76 0.0036
79 DAIRY INTOLERANCE 1 0.0036
80 BURNING MOUTH SYNDROME 2 0.0035
81 URGE INCONTINENCE 3 0.0034
82 FOOD REFUSAL 3 0.0034
83 CATHETER SITE CELLULITIS 1 0.0034
84 SENSE OF OPPRESSION 4 0.0034
85 THYROID CYST 2 0.0034
86 PRODUCT DISPENSING ERROR 73 0.0033
87 PRODUCT RESIDUE PRESENT 18 0.0033
88 PLEUROTHOTONUS 3 0.0033
89 STOMA SITE DISCHARGE 9 0.0033
90 DELUSION 51 0.0033
91 DEFIANT BEHAVIOUR 1 0.0032
92 HOSPICE CARE 32 0.0032
93 OVARIAN DISORDER 3 0.0032
94 INHIBITORY DRUG INTERACTION 5 0.0032
95 ANKLE DEFORMITY 1 0.0031
96 INFUSION SITE IRRITATION 4 0.0031
97 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
98 DRUG EFFECT FASTER THAN EXPECTED 1 0.0030
99 CATHETER SITE IRRITATION 1 0.0030
100 FEMALE ORGASMIC DISORDER 1 0.0030
101 HALLUCINATION, TACTILE 2 0.0030
102 NASAL DISCHARGE DISCOLOURATION 4 0.0029
103 BEZOAR 4 0.0029
104 POSTURE ABNORMAL 9 0.0028
105 ANAESTHESIA 1 0.0027
106 CHEMICAL POISONING 1 0.0027
107 CORNEAL REFLEX DECREASED 1 0.0027
108 GASTROSTOMY 4 0.0026
109 ASYMPTOMATIC COVID-19 1 0.0025
110 ENERGY INCREASED 15 0.0025
111 PROSTATIC OPERATION 3 0.0025
112 EXCESSIVE GRANULATION TISSUE 2 0.0025
113 AKINESIA 5 0.0024
114 DISEASE COMPLICATION 11 0.0024
115 TONGUE MOVEMENT DISTURBANCE 2 0.0023
116 BELLIGERENCE 1 0.0023
117 DEVICE LOOSENING 2 0.0023
118 SOLILOQUY 2 0.0023
119 FUNGAL FOOT INFECTION 1 0.0023
120 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
121 GENERAL SYMPTOM 17 0.0023
122 GASTRIC FISTULA 1 0.0022
123 DEVICE KINK 8 0.0022
124 HEAD TITUBATION 3 0.0022
125 ABULIA 2 0.0022
126 EATING DISORDER SYMPTOM 1 0.0022
127 LIVING IN RESIDENTIAL INSTITUTION 4 0.0021
128 IMPULSIVE BEHAVIOUR 8 0.0021
129 LOGORRHOEA 7 0.0020
130 STOMA COMPLICATION 2 0.0020
131 BLADDER OBSTRUCTION 1 0.0019
132 ABDOMINAL INJURY 1 0.0019
133 LIVEDO RETICULARIS 4 0.0019
134 TEETH BRITTLE 2 0.0019
135 TRAUMATIC HAEMATOMA 2 0.0019
136 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
137 DEVICE OCCLUSION 26 0.0018
138 INFUSION SITE MASS 2 0.0018
139 NONSPECIFIC REACTION 10 0.0018
140 DEMENTIA WITH LEWY BODIES 2 0.0018
141 THERAPY PARTIAL RESPONDER 28 0.0018
142 THYROTOXIC CRISIS 2 0.0018
143 DROOLING 12 0.0017
144 DISTRACTIBILITY 2 0.0017
145 ENTERAL NUTRITION 1 0.0017
146 INFUSION SITE INFECTION 4 0.0017
147 SOMNAMBULISM 11 0.0017
148 DIAPHRAGMATIC PARALYSIS 1 0.0017
149 OBSESSIVE THOUGHTS 3 0.0017
150 DYSMETRIA 1 0.0017
151 TREMOR 272 0.0016
152 CONSTIPATION 357 0.0016
153 INFUSION SITE WARMTH 2 0.0016
154 PERSECUTORY DELUSION 4 0.0016
155 MUSCLE RIGIDITY 19 0.0016
156 SLEEP DISORDER 111 0.0016
157 SLOW RESPONSE TO STIMULI 2 0.0015
158 ADVERSE DRUG REACTION 138 0.0015
159 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
160 CONDITION AGGRAVATED 464 0.0015
161 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
162 HALLUCINATION, AUDITORY 23 0.0014
163 MOVEMENT DISORDER 46 0.0014
164 THERAPEUTIC PROCEDURE 2 0.0014
165 DERMATITIS DIAPER 1 0.0014
166 HYPERKINESIA 3 0.0014
167 DEVICE ELECTRICAL FINDING 1 0.0014
168 BALANCE DISORDER 122 0.0014
169 IMMUNISATION REACTION 1 0.0014
170 INFUSION SITE BRUISING 3 0.0014
171 FINE MOTOR SKILL DYSFUNCTION 4 0.0014
172 APALLIC SYNDROME 1 0.0014
173 JUDGEMENT IMPAIRED 2 0.0014
174 BLOOD FOLATE DECREASED 1 0.0014
175 BACTERIAL DISEASE CARRIER 1 0.0014
176 DEVICE POWER SOURCE ISSUE 4 0.0014
177 ADVERSE REACTION 18 0.0014
178 GASTROINTESTINAL ULCER 3 0.0014
179 BLISTER RUPTURE 1 0.0013
180 PARANOIA 23 0.0013
181 INDIFFERENCE 1 0.0013
182 NIGHTMARE 46 0.0013
183 BRAIN OPERATION 3 0.0013
184 READING DISORDER 3 0.0013
185 STOMA SITE HAEMORRHAGE 2 0.0013
186 GRIMACING 1 0.0013
187 STARING 3 0.0012
188 DIZZINESS POSTURAL 12 0.0012
189 PRODUCT DOSE OMISSION ISSUE 363 0.0012
190 SKULL FRACTURE 2 0.0012
191 INCONTINENCE 13 0.0012
192 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
193 OXYGEN THERAPY 2 0.0012
194 ILLUSION 2 0.0012
195 GASTRIC DILATATION 2 0.0012
196 ABNORMAL DREAMS 33 0.0012
197 SLEEP TERROR 5 0.0012
198 SEIZURE LIKE PHENOMENA 2 0.0012
199 ENTERITIS INFECTIOUS 2 0.0012
200 LAZINESS 2 0.0012
201 HEPATIC CANCER METASTATIC 1 0.0012
202 CRANIOFACIAL FRACTURE 1 0.0012
203 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
204 DEVICE USE ISSUE 20 0.0011
205 DISEASE PROGRESSION 135 0.0011
206 INFUSION SITE DISCOLOURATION 1 0.0011
207 FOOD INTERACTION 2 0.0011
208 DYSTONIA 22 0.0011
209 PRODUCT CLEANING INADEQUATE 3 0.0011
210 YAWNING 3 0.0011
211 HIP FRACTURE 36 0.0011
212 GAMBLING DISORDER 3 0.0011
213 HIP SURGERY 6 0.0011
214 DEVICE ALARM ISSUE 2 0.0011
215 INTENTIONAL UNDERDOSE 8 0.0011
216 HYPERSEXUALITY 2 0.0011
217 THERAPEUTIC RESPONSE SHORTENED 36 0.0011
218 ADVERSE FOOD REACTION 1 0.0011
219 INFUSION SITE ERYTHEMA 9 0.0011
220 INFECTED SKIN ULCER 2 0.0011
221 FALL 352 0.0011
222 MYELOPATHY 2 0.0011
223 COMMUNICATION DISORDER 4 0.0010
224 PNEUMONIA ASPIRATION 26 0.0010
225 DEMENTIA 29 0.0010
226 ORTHOSTATIC HYPOTENSION 18 0.0010
227 BLADDER CATHETERISATION 1 0.0010
228 CONVERSION DISORDER 2 0.0010
229 APPLICATION SITE BRUISE 1 0.0010
230 NECK INJURY 3 0.0010
231 JOINT NOISE 2 0.0010
232 HEAD INJURY 32 0.0010
233 DIPLEGIA 2 0.0010
234 CEREBRAL ATROPHY 4 0.0010
235 ANAL INCONTINENCE 9 0.0010
236 AUTONOMIC NEUROPATHY 1 0.0010
237 DECUBITUS ULCER 8 0.0010
238 COMPULSIVE SHOPPING 2 0.0010
239 CORONAVIRUS TEST POSITIVE 1 0.0010
240 HYPERPARATHYROIDISM 2 0.0010
241 CHEST INJURY 2 0.0010
242 GAIT INABILITY 32 0.0010
243 FOREIGN BODY IN THROAT 3 0.0010
244 HALLUCINATIONS, MIXED 4 0.0010
245 TORTICOLLIS 2 0.0009
246 SCREAMING 6 0.0009
247 GAIT DISTURBANCE 180 0.0009
248 DEVICE INEFFECTIVE 1 0.0009
249 DEREALISATION 2 0.0009
250 CONFUSIONAL STATE 150 0.0009
251 INCOHERENT 6 0.0009
252 DELIRIUM 32 0.0009
253 INFUSION SITE HAEMORRHAGE 3 0.0009
254 WALKING AID USER 6 0.0009
255 BACTERIAL TEST POSITIVE 2 0.0009
256 HYPOKINESIA 13 0.0009
257 CATHETER SITE DISCHARGE 1 0.0009
258 INSOMNIA 229 0.0009
259 HYPORESPONSIVE TO STIMULI 1 0.0009
260 DIZZINESS 423 0.0008
261 HOSPITALISATION 130 0.0008
262 GLOSSITIS 3 0.0008
263 VOLVULUS 2 0.0008
264 DEATH 726 0.0008
265 COLON OPERATION 1 0.0008
266 ADVERSE EVENT 77 0.0008
267 HAEMATOMA MUSCLE 1 0.0008
268 AGITATION 61 0.0008
269 DENTAL OPERATION 2 0.0008
270 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
271 FRACTURED SACRUM 1 0.0008
272 INFREQUENT BOWEL MOVEMENTS 2 0.0008
273 SPEECH DISORDER 42 0.0008
274 GASTROINTESTINAL TUBE INSERTION 2 0.0008
275 PRODUCT DOSE OMISSION 52 0.0008
276 FRACTURED COCCYX 1 0.0008
277 DRY MOUTH 64 0.0008
278 INITIAL INSOMNIA 8 0.0008
279 ACTINIC KERATOSIS 2 0.0008
280 BRAIN FOG 12 0.0008
281 PERSONALITY DISORDER 2 0.0008
282 EXFOLIATIVE RASH 2 0.0008
283 DISORIENTATION 30 0.0008
284 CORONAVIRUS INFECTION 5 0.0008
285 HIRSUTISM 1 0.0008
286 ANAESTHETIC COMPLICATION 2 0.0007
287 TIC 4 0.0007
288 HYPERSOMNIA 21 0.0007
289 SPINAL OPERATION 9 0.0007
290 MUSCULOSKELETAL STIFFNESS 64 0.0007
291 ASPIRATION 8 0.0007
292 CORNEAL ABRASION 1 0.0007
293 DISCHARGE 1 0.0007
294 RESTLESS LEGS SYNDROME 13 0.0007
295 CEREBELLAR HAEMORRHAGE 1 0.0007
296 HYPERTONIC BLADDER 2 0.0007
297 IMMOBILE 3 0.0007
298 SOMNOLENCE 138 0.0007
299 LUMBAR SPINAL STENOSIS 2 0.0007
300 DYSPHEMIA 3 0.0007
301 CARDIAC FIBRILLATION 1 0.0007
302 MUSCLE TIGHTNESS 11 0.0007
303 CATARACT OPERATION 4 0.0007
304 FEELING DRUNK 5 0.0007
305 AXILLARY PAIN 1 0.0007
306 INFUSION SITE REACTION 2 0.0007
307 URINE ANALYSIS ABNORMAL 2 0.0007
308 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
309 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
310 PERSONALITY CHANGE 6 0.0006
311 FEELING OF DESPAIR 3 0.0006
312 INFUSION SITE SWELLING 4 0.0006
313 FUNGAEMIA 1 0.0006
314 SPUTUM DISCOLOURED 6 0.0006
315 INAPPROPRIATE AFFECT 1 0.0006
316 ABNORMAL BEHAVIOUR 25 0.0006
317 DISINHIBITION 1 0.0006
318 ANGER 21 0.0006
319 DIPLOPIA 16 0.0006
320 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
321 DENTAL IMPLANTATION 1 0.0006
322 MANIA 10 0.0006
323 MUSCLE TWITCHING 14 0.0006
324 ANEURYSM 3 0.0006
325 ARTHROPOD STING 1 0.0006
326 FLUID INTAKE REDUCED 3 0.0006
327 ANXIETY DISORDER 2 0.0006
328 TERMINAL STATE 4 0.0006
329 DYSPHAGIA 56 0.0006
330 MOTOR DYSFUNCTION 6 0.0006
331 CHOREA 1 0.0006
332 THERAPEUTIC PRODUCT EFFECT DECREASED 26 0.0006
333 FEELING JITTERY 11 0.0006
334 HYPOPNOEA 2 0.0006
335 CATATONIA 3 0.0006
336 EMOTIONAL POVERTY 1 0.0006
337 INFUSION SITE DISCHARGE 1 0.0006
338 GASTROINTESTINAL OEDEMA 1 0.0006
339 THERAPY CESSATION 29 0.0006
340 HAEMORRHAGIC DIATHESIS 2 0.0006
341 AGGRESSION 28 0.0006
342 DEVICE PLACEMENT ISSUE 2 0.0006
343 COGNITIVE DISORDER 26 0.0006
344 BRUXISM 3 0.0006
345 BEHAVIOUR DISORDER 3 0.0006
346 RENAL TRANSPLANT 2 0.0006
347 MOOD ALTERED 15 0.0005
348 ESSENTIAL HYPERTENSION 1 0.0005
349 DISORGANISED SPEECH 1 0.0005
350 PSYCHIATRIC SYMPTOM 4 0.0005
351 WOUND HAEMORRHAGE 2 0.0005
352 INJECTION SITE CELLULITIS 1 0.0005
353 HYPERACUSIS 2 0.0005
354 IMPATIENCE 1 0.0005
355 URINARY TRACT INFECTION 90 0.0005
356 FACE INJURY 2 0.0005
357 DEVICE ISSUE 47 0.0005
358 HIP ARTHROPLASTY 8 0.0005
359 ADRENAL DISORDER 1 0.0005
360 MOUTH SWELLING 3 0.0005
361 ARTERIAL THROMBOSIS 1 0.0005
362 MOBILITY DECREASED 37 0.0005
363 HYPOGEUSIA 1 0.0005
364 THERAPY CHANGE 5 0.0005
365 SKIN ODOUR ABNORMAL 2 0.0005
366 KNEE OPERATION 5 0.0005
367 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
368 LETHARGY 29 0.0005
369 BLOOD PRESSURE ABNORMAL 10 0.0005
370 EJACULATION FAILURE 1 0.0005
371 CARDIAC DISCOMFORT 1 0.0005
372 SPINAL FUSION SURGERY 2 0.0005
373 SLUGGISHNESS 5 0.0005
374 ASPHYXIA 4 0.0005
375 RIB FRACTURE 10 0.0005
376 FEELING ABNORMAL 116 0.0005
377 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
378 MIDDLE INSOMNIA 9 0.0005
379 DRUG INEFFECTIVE 634 0.0005
380 DEVICE MATERIAL ISSUE 1 0.0005
381 PSYCHOTIC DISORDER 14 0.0005
382 URINARY INCONTINENCE 14 0.0005
383 SHOULDER OPERATION 2 0.0005
384 CATHETER SITE ERYTHEMA 1 0.0005
385 INFUSION SITE PAIN 6 0.0005
386 EXOPHTHALMOS 1 0.0005
387 POOR QUALITY SLEEP 10 0.0005
388 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
389 CHOKING 9 0.0005
390 SKIN LACERATION 5 0.0005
391 NERVOUSNESS 24 0.0005
392 BRADYPHRENIA 3 0.0005
393 BLOOD PRESSURE FLUCTUATION 11 0.0005
394 COLONOSCOPY 1 0.0005
395 PRESCRIBED UNDERDOSE 9 0.0005
396 WHEELCHAIR USER 2 0.0004
397 SKIN MASS 3 0.0004
398 DYSSTASIA 13 0.0004
399 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
400 MICTURITION URGENCY 5 0.0004
401 NEPHROTIC SYNDROME 3 0.0004
402 RENAL FUNCTION TEST ABNORMAL 2 0.0004
403 THINKING ABNORMAL 8 0.0004
404 SURGERY 25 0.0004
405 INGROWING NAIL 1 0.0004
406 SKIN ABRASION 2 0.0004
407 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
408 ATAXIA 5 0.0004
409 PRODUCT PRESCRIBING ERROR 10 0.0004
410 GASTROINTESTINAL OBSTRUCTION 1 0.0004
411 RASH VESICULAR 2 0.0004
412 GUILLAIN-BARRE SYNDROME 2 0.0004
413 ILL-DEFINED DISORDER 25 0.0004
414 MAJOR DEPRESSION 3 0.0004
415 BREATH ODOUR 1 0.0004
416 HORMONE LEVEL ABNORMAL 2 0.0004
417 PERIPHERAL SWELLING 63 0.0004
418 HAEMATOLOGICAL INFECTION 1 0.0004
419 VITREOUS FLOATERS 4 0.0004
420 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73 0.0004
421 MUSCULAR WEAKNESS 46 0.0004
422 ACUTE PSYCHOSIS 1 0.0004
423 INABILITY TO AFFORD MEDICATION 4 0.0004
424 MEMORY IMPAIRMENT 55 0.0004
425 SALIVARY HYPERSECRETION 4 0.0004
426 CATHETER SITE HAEMORRHAGE 1 0.0004
427 HOSTILITY 1 0.0004
428 DYSPHONIA 23 0.0004
429 DIABETIC COMPLICATION 1 0.0004
430 CANCER PAIN 1 0.0004
431 FEMORAL NECK FRACTURE 2 0.0004
432 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
433 BLOOD CHLORIDE DECREASED 1 0.0004
434 UNRESPONSIVE TO STIMULI 10 0.0004
435 PELVIC FRACTURE 3 0.0004
436 HERNIA REPAIR 1 0.0004
437 POLLAKIURIA 16 0.0004
438 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
439 AFFECTIVE DISORDER 3 0.0004
440 ABDOMINAL DISCOMFORT 64 0.0004
441 BEDRIDDEN 5 0.0004
442 THERAPY INTERRUPTED 27 0.0004
443 BLOOD POTASSIUM ABNORMAL 1 0.0004
444 COMPRESSION FRACTURE 2 0.0004
445 FRACTURE 7 0.0004
446 GASTRIC PERFORATION 1 0.0004
447 POLYURIA 3 0.0004
448 IRRITABILITY 22 0.0004
449 WOUND INFECTION 4 0.0004
450 CHOKING SENSATION 2 0.0004
451 COORDINATION ABNORMAL 5 0.0004
452 DIABETIC COMA 1 0.0004
453 TARDIVE DYSKINESIA 10 0.0004
454 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
455 BREAST CANCER STAGE IV 1 0.0004
456 EJACULATION DISORDER 1 0.0004
457 INTERNAL HAEMORRHAGE 4 0.0003
458 PARALYSIS 5 0.0003
459 SUBDURAL HAEMATOMA 5 0.0003
460 HEART VALVE INCOMPETENCE 1 0.0003
461 HYPOGLYCAEMIC COMA 1 0.0003
462 ENTEROCOLITIS 2 0.0003
463 DYSARTHRIA 13 0.0003
464 HYPERVENTILATION 2 0.0003
465 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
466 ASTHENIA 128 0.0003
467 CARDIAC PACEMAKER INSERTION 2 0.0003
468 WRIST FRACTURE 4 0.0003
469 OROPHARYNGEAL DISCOMFORT 3 0.0003
470 HIV INFECTION 1 0.0003
471 MENTAL IMPAIRMENT 8 0.0003
472 EYE INJURY 1 0.0003
473 TENSION 2 0.0003
474 EPILEPSY 10 0.0003
475 INSURANCE ISSUE 5 0.0003
476 PNEUMONIA BACTERIAL 3 0.0003
477 UROSEPSIS 3 0.0003
478 LIMB DISCOMFORT 10 0.0003
479 DEVICE DISLOCATION 14 0.0003
480 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65 0.0003
481 SECRETION DISCHARGE 4 0.0003
482 LEUKAEMIA 3 0.0003
483 BLEPHAROSPASM 2 0.0003
484 INFUSION SITE PRURITUS 1 0.0003
485 SPINAL DISORDER 3 0.0003
486 INCREASED APPETITE 6 0.0003
487 MOOD SWINGS 10 0.0003
488 HAEMOGLOBIN ABNORMAL 2 0.0003
489 ILLNESS 32 0.0003
490 CHROMATURIA 7 0.0003
491 CARDIAC FLUTTER 2 0.0003
492 BACK DISORDER 5 0.0003
493 PRODUCT AVAILABILITY ISSUE 7 0.0003
494 HEPATIC NEOPLASM 1 0.0003
495 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
496 KIDNEY INFECTION 6 0.0003
497 ANXIETY 87 0.0003
498 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
499 UPPER LIMB FRACTURE 6 0.0003
500 RESTLESSNESS 11 0.0003
501 DRY THROAT 3 0.0003
502 FLUID RETENTION 15 0.0003
503 IMPAIRED GASTRIC EMPTYING 4 0.0003
504 AMNESIA 19 0.0003
505 PERIPHERAL COLDNESS 4 0.0003
506 FEMUR FRACTURE 9 0.0003
507 DEVICE DEFECTIVE 5 0.0003
508 FORMICATION 2 0.0003
509 APHONIA 4 0.0003
510 BLOOD PRESSURE DECREASED 19 0.0003
511 HANGOVER 1 0.0003
512 DEPRESSIVE SYMPTOM 1 0.0003
513 LOSS OF CONSCIOUSNESS 36 0.0003
514 PRODUCT SUPPLY ISSUE 2 0.0003
515 COVID-19 49 0.0003
516 RHINORRHOEA 18 0.0003
517 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13 0.0003
518 VISUAL FIELD DEFECT 2 0.0003
519 MENTAL DISORDER 12 0.0003
520 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
521 TOOTH FRACTURE 3 0.0003
522 DEVICE DIFFICULT TO USE 18 0.0003
523 HYPOMANIA 1 0.0003
524 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
525 CEREBRAL DISORDER 2 0.0003
526 URINARY RETENTION 9 0.0003
527 PAROSMIA 2 0.0003
528 HYPOTENSION 53 0.0003
529 MUSCULOSKELETAL DISORDER 5 0.0003
530 MUSCLE SPASMS 48 0.0003
531 FATIGUE 203 0.0003
532 HERNIA 5 0.0003
533 ANKLE FRACTURE 4 0.0003
534 PRESCRIBED OVERDOSE 5 0.0003
535 RASH MACULAR 9 0.0003
536 FAECES HARD 1 0.0003
537 CARDIOPULMONARY FAILURE 1 0.0003
538 MULTIPLE ALLERGIES 2 0.0003
539 NAUSEA 200 0.0003
540 MENTAL STATUS CHANGES 7 0.0003
541 HYPERPHAGIA 1 0.0003
542 ATRIAL FLUTTER 2 0.0003
543 AZOTAEMIA 1 0.0003
544 CEREBROVASCULAR ACCIDENT 42 0.0002
545 PRODUCT PHYSICAL ISSUE 5 0.0002
546 ENURESIS 1 0.0002
547 FRUSTRATION TOLERANCE DECREASED 2 0.0002
548 PRODUCT ADMINISTRATION ERROR 5 0.0002
549 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
550 FEEDING DISORDER 5 0.0002
551 DEPRESSED MOOD 13 0.0002
552 GOITRE 1 0.0002
553 HICCUPS 2 0.0002
554 TENDON RUPTURE 3 0.0002
555 COUGH 68 0.0002
556 PRODUCT USE IN UNAPPROVED INDICATION 60 0.0002
557 SPINAL COMPRESSION FRACTURE 2 0.0002
558 ILEUS 3 0.0002
559 ERECTION INCREASED 1 0.0002
560 INTESTINAL OBSTRUCTION 9 0.0002
561 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
562 EATING DISORDER 5 0.0002
563 FACIAL PARALYSIS 2 0.0002
564 RETCHING 5 0.0002
565 DRUG INTERACTION 37 0.0002
566 ABNORMAL SENSATION IN EYE 1 0.0002
567 CHAPPED LIPS 1 0.0002
568 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
569 PRODUCT COMMUNICATION ISSUE 2 0.0002
570 GINGIVAL SWELLING 1 0.0002
571 HEAD DISCOMFORT 4 0.0002
572 CATHETERISATION CARDIAC 1 0.0002
573 ILEUS PARALYTIC 1 0.0002
574 DECREASED APPETITE 52 0.0002
575 CEREBRAL HAEMORRHAGE 8 0.0002
576 HYPOAESTHESIA 33 0.0002
577 LIP DRY 2 0.0002
578 CRYING 8 0.0002
579 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
580 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
581 EYE OPERATION 1 0.0002
582 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
583 MALAISE 95 0.0002
584 VERTIGO 13 0.0002
585 SEASONAL ALLERGY 3 0.0002
586 SYNCOPE 21 0.0002
587 SLEEP APNOEA SYNDROME 4 0.0002
588 HUMERUS FRACTURE 1 0.0002
589 DRUG INTOLERANCE 20 0.0002
590 UNDERDOSE 15 0.0002
591 PARKINSONISM 2 0.0002
592 RASH PRURITIC 11 0.0002
593 BLOOD PRESSURE INCREASED 31 0.0002
594 HYPERVOLAEMIA 1 0.0002
595 LIGAMENT SPRAIN 2 0.0002
596 PRODUCT USE ISSUE 38 0.0002
597 VISUAL IMPAIRMENT 25 0.0002
598 BLADDER DISORDER 2 0.0002
599 COLON CANCER 3 0.0002
600 HYPERNATRAEMIA 1 0.0002
601 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
602 HYPERAMMONAEMIA 1 0.0002
603 SPINAL FRACTURE 4 0.0002
604 DRUG TOLERANCE 1 0.0002
605 HYPOTHERMIA 2 0.0002
606 EYELID PTOSIS 2 0.0002
607 TOOTH ABSCESS 2 0.0002
608 SUBARACHNOID HAEMORRHAGE 2 0.0002
609 EUPHORIC MOOD 2 0.0002
610 EAR DISCOMFORT 2 0.0002
611 EMOTIONAL DISORDER 6 0.0002
612 HYPERHIDROSIS 25 0.0002
613 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
614 WEIGHT DECREASED 54 0.0002
615 FAILURE TO THRIVE 1 0.0002
616 SWOLLEN TONGUE 6 0.0002
617 SEDATION 5 0.0002
618 JOINT DISLOCATION 2 0.0002
619 SUDDEN DEATH 2 0.0002
620 DEPRESSION 43 0.0002
621 CYSTITIS 6 0.0002
622 INJECTION SITE DISCHARGE 1 0.0002
623 FEAR 5 0.0002
624 SKIN CANCER 4 0.0002
625 BACK INJURY 2 0.0002
626 FAECALOMA 1 0.0002
627 PNEUMONIA 59 0.0002
628 ASTHENOPIA 1 0.0002
629 SEIZURE 21 0.0002
630 GASTROINTESTINAL PAIN 2 0.0002
631 INJECTION SITE NODULE 2 0.0002
632 FOOT DEFORMITY 2 0.0002
633 VIRAL INFECTION 6 0.0002
634 DEHYDRATION 24 0.0002
635 NEOPLASM MALIGNANT 12 0.0002
636 HEART RATE ABNORMAL 1 0.0002
637 WOUND 5 0.0002
638 MALNUTRITION 2 0.0002
639 SKIN INFECTION 2 0.0002
640 CONTUSION 17 0.0002
641 IMPAIRED DRIVING ABILITY 2 0.0002
642 DERMATITIS CONTACT 2 0.0002
643 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
644 ATRIAL FIBRILLATION 17 0.0002
645 SKIN DISCOLOURATION 8 0.0002
646 EXERCISE TOLERANCE DECREASED 1 0.0002
647 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
648 DEVICE BREAKAGE 7 0.0002
649 SPINAL PAIN 2 0.0002
650 DECREASED INTEREST 1 0.0002
651 BACTERAEMIA 2 0.0002
652 THIRST 3 0.0002
653 ACCIDENT 2 0.0002
654 DISTURBANCE IN ATTENTION 9 0.0002
655 PRESYNCOPE 4 0.0002
656 NEURALGIA 4 0.0002
657 TREATMENT NONCOMPLIANCE 9 0.0002
658 DERMATITIS ACNEIFORM 1 0.0002
659 SMALL INTESTINAL OBSTRUCTION 2 0.0002
660 TOOTH EXTRACTION 2 0.0002
661 INFUSION SITE EXTRAVASATION 1 0.0002
662 BLOOD URINE PRESENT 3 0.0002
663 INJECTION SITE IRRITATION 2 0.0002
664 SEROTONIN SYNDROME 3 0.0002
665 LOWER LIMB FRACTURE 3 0.0002
666 THROAT IRRITATION 7 0.0002
667 GLAUCOMA 3 0.0002
668 NODULE 2 0.0002
669 JOINT STIFFNESS 4 0.0002
670 DYSGRAPHIA 1 0.0002
671 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
672 SKIN DISORDER 5 0.0001
673 FREQUENT BOWEL MOVEMENTS 4 0.0001
674 SINUS CONGESTION 2 0.0001
675 TASTE DISORDER 3 0.0001
676 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
677 ABNORMAL LOSS OF WEIGHT 1 0.0001
678 AKATHISIA 2 0.0001
679 EYE MOVEMENT DISORDER 1 0.0001
680 ABDOMINAL PAIN UPPER 30 0.0001
681 UNEVALUABLE EVENT 11 0.0001
682 AUTOIMMUNE HEPATITIS 1 0.0001
683 EXTRASYSTOLES 1 0.0001
684 CARPAL TUNNEL SYNDROME 2 0.0001
685 DEFAECATION URGENCY 1 0.0001
686 PAIN IN EXTREMITY 42 0.0001
687 KNEE ARTHROPLASTY 3 0.0001
688 HAND FRACTURE 1 0.0001
689 JOINT INJURY 3 0.0001
690 INTENTIONAL DOSE OMISSION 4 0.0001
691 OEDEMA PERIPHERAL 17 0.0001
692 IMPAIRED QUALITY OF LIFE 2 0.0001
693 DEVICE LEAKAGE 6 0.0001
694 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
695 CARDIAC FAILURE CONGESTIVE 11 0.0001
696 CHEST DISCOMFORT 14 0.0001
697 DYSURIA 5 0.0001
698 PULMONARY MASS 2 0.0001
699 HAEMORRHAGE INTRACRANIAL 2 0.0001
700 HEADACHE 83 0.0001
701 DYSPEPSIA 13 0.0001
702 HEART RATE INCREASED 13 0.0001
703 ACIDOSIS 1 0.0001
704 BOWEL MOVEMENT IRREGULARITY 1 0.0001
705 SHOCK 3 0.0001
706 DISSOCIATION 1 0.0001
707 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
708 ATRIOVENTRICULAR BLOCK 1 0.0001
709 HYPOALBUMINAEMIA 1 0.0001
710 GASTROINTESTINAL INFLAMMATION 1 0.0001
711 FURUNCLE 1 0.0001
712 GINGIVAL PAIN 1 0.0001
713 SENSORY DISTURBANCE 2 0.0001
714 JOINT SWELLING 15 0.0001
715 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
716 VISION BLURRED 17 0.0001
717 FLATULENCE 7 0.0001
718 BLOOD POTASSIUM INCREASED 2 0.0001
719 CEREBRAL INFARCTION 3 0.0001
720 HYPERTENSION 26 0.0001
721 ABNORMAL FAECES 1 0.0001
722 RASH 53 0.0001
723 DRUG LEVEL INCREASED 2 0.0001
724 EXPIRED PRODUCT ADMINISTERED 4 0.0001
725 SUICIDAL IDEATION 11 0.0001
726 LIP SWELLING 4 0.0001
727 EOSINOPHIL COUNT INCREASED 1 0.0001
728 NASAL CONGESTION 7 0.0001
729 WITHDRAWAL SYNDROME 5 0.0001
730 SWELLING 11 0.0001
731 INFECTION 17 0.0001
732 VOMITING 55 0.0001
733 ERECTILE DYSFUNCTION 3 0.0001
734 CARDIAC OPERATION 1 0.0001
735 MUSCULOSKELETAL DISCOMFORT 2 0.0001
736 BLOOD MAGNESIUM DECREASED 1 0.0001
737 HEART RATE DECREASED 4 0.0001
738 HYPOXIA 4 0.0001
739 CARDIAC FAILURE 9 0.0001
740 ISCHAEMIC STROKE 2 0.0001
741 FACIAL PAIN 1 0.0001
742 THROMBOSIS 9 0.0001
743 GASTROINTESTINAL DISORDER 10 0.0001
744 GASTROINTESTINAL INFECTION 1 0.0001
745 PALPITATIONS 13 0.0001
746 SKIN LESION 3 0.0001
747 BRAIN NEOPLASM 1 0.0001
748 TINNITUS 5 0.0001
749 BACK PAIN 25 0.0001
750 SEPSIS 12 0.0001
751 RENAL DISORDER 5 0.0001
752 HEPATIC ENCEPHALOPATHY 1 0.0001
753 DIARRHOEA 69 0.0001
754 BLOOD SODIUM DECREASED 2 0.0001
755 FOOT FRACTURE 2 0.0001
756 GASTRIC ULCER 2 0.0001
757 INCORRECT DOSE ADMINISTERED 24 0.0001
758 POST PROCEDURAL COMPLICATION 2 0.0001
759 AFFECT LABILITY 1 0.0001
760 NASOPHARYNGITIS 19 0.0001
761 INTENTIONAL PRODUCT MISUSE 9 0.0001
762 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
763 PLASMA CELL MYELOMA 4 0.0001
764 SINUS DISORDER 2 0.0001
765 DYSPNOEA 57 0.0001
766 BLOOD POTASSIUM DECREASED 3 0.0001
767 BRAIN INJURY 1 0.0001
768 INJURY 7 0.0001
769 APHASIA 3 0.0001
770 CELLULITIS 5 0.0001
771 INTENTIONAL SELF-INJURY 2 0.0001
772 BODY TEMPERATURE INCREASED 2 0.0001
773 CARDIAC ARREST 8 0.0001
774 NEUROPATHY PERIPHERAL 9 0.0001
775 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
776 WEIGHT INCREASED 21 0.0001
777 BREAST PAIN 1 0.0001
778 BODY HEIGHT DECREASED 1 0.0001
779 HYPOACUSIS 4 0.0001
780 DECREASED ACTIVITY 1 0.0001
781 BIPOLAR DISORDER 1 0.0001
782 SEPTIC SHOCK 4 0.0001
783 PRODUCT PRESCRIBING ISSUE 2 0.0001
784 MYOCARDIAL INFARCTION 16 0.0001
785 CHOLELITHIASIS 3 0.0001
786 EYE DISORDER 3 0.0001
787 DENTAL CARIES 1 0.0001
788 MEDICATION ERROR 5 0.0001
789 HYPERTENSIVE CRISIS 1 0.0001
790 GLOSSODYNIA 2 0.0001
791 ORAL PAIN 2 0.0001
792 EYE PRURITUS 3 0.0001
793 SNEEZING 2 0.0001
794 PARAESTHESIA 14 0.0001
795 EYE INFECTION 1 0.0001
796 HEART RATE IRREGULAR 2 0.0001
797 HAEMATURIA 3 0.0001
798 GASTRIC DISORDER 3 0.0001
799 NEPHROLITHIASIS 4 0.0001
800 DEVICE USE ERROR 3 0.0001
801 HYPERSENSITIVITY 16 0.0001
802 ELECTROLYTE IMBALANCE 1 0.0001
803 BURNING SENSATION 6 0.0001
804 COVID-19 PNEUMONIA 1 0.0001
805 ARRHYTHMIA 4 0.0001
806 BLOOD IRON DECREASED 1 0.0001
807 COMPLETED SUICIDE 7 0.0001
808 RASH ERYTHEMATOUS 4 0.0001
809 RENAL IMPAIRMENT 7 0.0001
810 SKIN EXFOLIATION 7 0.0001
811 LOCALISED INFECTION 2 0.0001
812 STOMATITIS 5 0.0001
813 BURSITIS 1 0.0001
814 MYALGIA 14 0.0001
815 PANIC ATTACK 3 0.0001
816 ACCIDENTAL OVERDOSE 3 0.0001
817 LUNG DISORDER 4 0.0001
818 ENCEPHALOPATHY 2 0.0001
819 CYST 1 0.0001
820 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
821 INJECTION SITE DISCOLOURATION 1 0.0001
822 COLITIS 3 0.0001
823 GASTRIC CANCER 2 0.0001
824 HYPOPHAGIA 2 0.0001
825 ABDOMINAL PAIN 18 0.0001
826 DEEP VEIN THROMBOSIS 5 0.0001
827 CHILLS 9 0.0001
828 ABDOMINAL DISTENSION 8 0.0001
829 CARDIAC DISORDER 7 0.0001
830 LIMB INJURY 2 0.0001
831 ERYTHEMA 15 0.0001
832 DEVICE MECHANICAL ISSUE 1 0.0001
833 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
834 RESPIRATORY DISTRESS 2 0.0001
835 HUNGER 1 0.0001
836 ROAD TRAFFIC ACCIDENT 3 0.0001
837 PAIN 44 0.0001
838 NECK PAIN 4 0.0001
839 OXYGEN SATURATION DECREASED 4 0.0001
840 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
841 DIALYSIS 1 0.0001
842 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
843 RECTAL HAEMORRHAGE 3 0.0001
844 CARDIOGENIC SHOCK 1 0.0001
845 OVERDOSE 15 0.0001
846 ACCIDENTAL UNDERDOSE 1 0.0001
847 ANOSMIA 1 0.0001
848 APATHY 1 0.0001
849 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
850 PRURITUS 26 0.0001
851 DRY SKIN 9 0.0001
852 HYPOAESTHESIA ORAL 1 0.0001
853 CORONARY ARTERY DISEASE 2 0.0001
854 ECONOMIC PROBLEM 1 0.0001
855 SUICIDE ATTEMPT 4 0.0001
856 BLOOD COUNT ABNORMAL 1 0.0001
857 DEVICE FAILURE 1 0.0001
858 URTICARIA 11 0.0001
859 DISCOMFORT 4 0.0001
860 FEELING HOT 4 0.0001
861 TOXICITY TO VARIOUS AGENTS 11 0.0001
862 DEVICE RELATED INFECTION 1 0.0001
863 CHEST PAIN 12 0.0001
864 EJECTION FRACTION DECREASED 1 0.0001
865 BASAL CELL CARCINOMA 1 0.0001
866 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
867 ABSCESS 1 0.0001
868 INJECTION SITE BRUISING 5 0.0001
869 BLOOD GLUCOSE DECREASED 3 0.0001
870 NIGHT SWEATS 2 0.0001
871 RENAL FAILURE 8 0.0001
872 FUNGAL INFECTION 2 0.0001
873 CANDIDA INFECTION 1 0.0001
874 HEMIPARESIS 1 0.0001
875 SINUSITIS 6 0.0001
876 INFLAMMATION 3 0.0001
877 COLD SWEAT 1 0.0001
878 DRUG ERUPTION 1 0.0001
879 GOUT 1 0.0001
880 GASTROENTERITIS VIRAL 1 0.0001
881 DRUG EFFECT INCOMPLETE 2 0.0001
882 BONE DISORDER 1 0.0001
883 HAEMATOCHEZIA 3 0.0001
884 OROPHARYNGEAL PAIN 5 0.0001
885 CONJUNCTIVITIS 1 0.0001
886 INFLUENZA 6 0.0001
887 EYE SWELLING 2 0.0001
888 HEPATIC FUNCTION ABNORMAL 2 0.0001
889 HEPATIC CIRRHOSIS 1 0.0001
890 EYE PAIN 3 0.0001
891 HOT FLUSH 4 0.0001
892 MIGRAINE 5 0.0001
893 HERPES ZOSTER 3 0.0001
894 INJECTION SITE SWELLING 4 0.0001
895 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
896 ACUTE RESPIRATORY FAILURE 1 0.0001
897 ERUCTATION 1 0.0001
898 EAR PAIN 1 0.0001
899 HAEMORRHOIDS 1 0.0001
900 DISABILITY 1 0.0001
901 CATARACT 3 0.0001
902 INJECTION SITE HAEMORRHAGE 4 0.0001
903 FULL BLOOD COUNT DECREASED 1 0.0000
904 THERAPEUTIC RESPONSE DECREASED 3 0.0000
905 EXTRA DOSE ADMINISTERED 2 0.0000
906 PLEURAL EFFUSION 3 0.0000
907 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
908 CARDIO-RESPIRATORY ARREST 2 0.0000
909 OSTEOARTHRITIS 2 0.0000
910 IMPAIRED WORK ABILITY 1 0.0000
911 INTENTIONAL OVERDOSE 3 0.0000
912 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
913 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
914 FAECES DISCOLOURED 1 0.0000
915 SWELLING FACE 3 0.0000
916 BLOOD CREATININE INCREASED 3 0.0000
917 ALOPECIA 9 0.0000
918 PRODUCT STORAGE ERROR 4 0.0000
919 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
920 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
921 TACHYCARDIA 4 0.0000
922 HEPATIC ENZYME INCREASED 3 0.0000
923 HYPOKALAEMIA 2 0.0000
924 ARTHRALGIA 18 0.0000
925 DEVICE MALFUNCTION 3 0.0000
926 OCULAR HYPERAEMIA 2 0.0000
927 PULMONARY EMBOLISM 4 0.0000
928 DISEASE RECURRENCE 2 0.0000
929 COMA 2 0.0000
930 PRODUCTIVE COUGH 2 0.0000
931 DIABETIC KETOACIDOSIS 1 0.0000
932 EMOTIONAL DISTRESS 5 0.0000
933 HYPOGLYCAEMIA 2 0.0000
934 FIBROMYALGIA 1 0.0000
935 EXTRAPYRAMIDAL DISORDER 1 0.0000
936 DRY EYE 2 0.0000
937 ABDOMINAL PAIN LOWER 1 0.0000
938 CARDIOVASCULAR DISORDER 1 0.0000
939 DIABETES MELLITUS 3 0.0000
940 HAEMATOMA 1 0.0000
941 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
942 MUSCULOSKELETAL PAIN 2 0.0000
943 PANCREATITIS 2 0.0000
944 BRADYCARDIA 2 0.0000
945 OFF LABEL USE 33 0.0000
946 EAR INFECTION 1 0.0000
947 BLOOD GLUCOSE INCREASED 7 0.0000
948 BLOOD BILIRUBIN INCREASED 1 0.0000
949 OEDEMA 2 0.0000
950 DIVERTICULITIS 1 0.0000
951 FEELING COLD 1 0.0000
952 HAEMOPTYSIS 1 0.0000
953 BLISTER 2 0.0000
954 HYPONATRAEMIA 2 0.0000
955 ASTHMA 4 0.0000
956 ANGINA PECTORIS 1 0.0000
957 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
958 ASCITES 1 0.0000
959 WHEEZING 2 0.0000
960 HEPATIC FAILURE 1 0.0000
961 INJECTION SITE ERYTHEMA 4 0.0000
962 BREAST CANCER 3 0.0000
963 ANAEMIA 6 0.0000
964 IMPAIRED HEALING 1 0.0000
965 FLUSHING 3 0.0000
966 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
967 PYREXIA 10 0.0000
968 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
969 HYPERGLYCAEMIA 1 0.0000
970 BRONCHITIS 2 0.0000
971 DYSGEUSIA 2 0.0000
972 EPISTAXIS 2 0.0000
973 PROSTATE CANCER 2 0.0000
974 DRUG WITHDRAWAL SYNDROME 2 0.0000
975 HAEMOGLOBIN DECREASED 2 0.0000
976 HAEMORRHAGE 2 0.0000
977 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
978 DRUG DEPENDENCE 3 0.0000
979 EYE IRRITATION 1 0.0000
980 BONE PAIN 1 0.0000
981 BLADDER CANCER 1 0.0000
982 INJECTION SITE PAIN 5 0.0000
983 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
984 DEVICE EXPULSION 1 0.0000
985 ACNE 1 0.0000
986 ACUTE KIDNEY INJURY 2 0.0000
987 ARTHRITIS 1 0.0000
988 INFLUENZA LIKE ILLNESS 1 0.0000
989 NO ADVERSE EVENT 2 0.0000